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CD4+ T follicular helper (TFH) cells support germinal center (GC) re-
actions promoting humoral immunity. Dendritic cell (DC) diversifica-
tion into genetically distinct subsets allows for specialization in
promoting responses against several types of pathogens. Whether
any classical DC (cDC) subset is required for humoral immunity is
unknown, however. We tested several genetic models that selec-
tively ablate distinct DC subsets in mice for their impact on splenic
GC reactions. We identified a requirement for Notch2-dependent
cDC2s, but not Batf3-dependent cDC1s or Klf4-dependent cDC2s,
in promoting TFH and GC B cell formation in response to sheep
red blood cells and inactivated Listeria monocytogenes. This effect
was mediated independent of Il2ra and several Notch2-dependent
genes expressed in cDC2s, including Stat4 and Havcr2. Notch2 sig-
naling during cDC2 development also substantially reduced the ef-
ficiency of cDC2s for presentation ofMHC class II-restricted antigens,
limiting the strength of CD4 T cell activation. Together, these results
demonstrate a nonredundant role for the Notch2-dependent cDC2
subset in supporting humoral immune responses.
dendritic cell | T follicular helper cell | germinal center
Classical dendritic cells (cDCs) (1) comprise two major line-ages, distinguished by CD8α, CD24, XCR1, and CD103 ex-
pression by cDC1s and by CD4, Sirpα, and CD11b expression by
cDC2s (2–4). cDC1s and cDC2s use distinct transcriptional
programs for development and exert distinct functions in vivo (2,
3), exhibiting specialization for activation of CD8+ and CD4+
T cells, respectively (5–7). cDC1s require Irf8, Batf3, Id2, and
Nfil3 for development and cross-present antigens to CD8+
T cells for antiviral and antitumor immunity (3). cDC2s develop
independent of Irf8, Batf3, Id2, and Nfil3, but require Irf4 for
normal function (8). cDC2s require Irf4 to support type II and
type III immune responses (9–14). Klf4 is required by cDC2s to
sustain type II responses (15), while Notch2 is required for type
III responses in defense against Citrobacter rodentium (16, 17).
Recent work has suggested that cDC2s might mediate T fol-
licular helper (TFH) responses and germinal center (GC) reac-
tions. TFH cells were identified as follicular homing cells that
express CXCR5 and PD-1 (18–20) and later found to require the
transcription factor Bcl6 for their differentiation (21–23). Gen-
eral depletion of cDCs using CD11c-DTR (24) or Zbtb46-DTR
(25) impaired TFH differentiation during Toxoplasma gondii in-
fection (26), prevented humoral responses to allogeneic RBCs
(27), and inhibited IgA class-switching in Peyer’s patches (PPs)
(28). Recently, secretion of the IL-2 receptor CD25 by cDCs was
found to support TFH differentiation in response to sheep red
blood cell (SRBC) immunization (29). A separate study showed
that CXCR5 expression by DCs and T cells was required for TFH
differentiation in response to the round worm Heligmosomoides
polygyrus (30). Antigen targeting to cDC1s and cDC2s using anti-
DEC205 and anti-DCIR2, respectively, showed that cDC2s are
strong inducers of humoral responses (31). Furthermore, cDC2s
were recently shown to be involved in some antibody responses,
with ItgaxCreIrf4f/f mice, but not Batf3−/− mice, showing impaired
antibody responses to allogeneic RBCs (27). In addition, mi-
gration of cDC2s from the lung to the mediastinal lymph nodes
was required to induce TFH differentiation in response to soluble
protein (32). Finally, Batf3−/− mice generate TFH in response to
immunization with SRBCs (29).
Here we extended our previous analysis of the in vivo function
of Notch2-dependent cDCs by examining TFH differentiation and
GC responses in response to several forms of immunization. We
find that the Notch2-dependent ESAM+ cDC2 subset is required
in two models of inducible TFH differentiation and GC reaction
in the spleen. Although the mechanism for this requirement
remains unclear, we have extended the characterization of the
Notch2-dependent transcriptional program in cDC2s, identifying
several potential targets that merit evaluation, and identified an
accompanying Notch2-dependent reduction of CD4+ T cell re-
sponse to antigens presented by DC2s acquired during terminal
maturation.
Results
Notch2-Dependent DCs Are Required for GC Reactions Induced by
SRBCs and Heat-Killed Listeria. We previously examined mice
with conditional deletion of Notch2 in the cDC2s induced by
CD11c-Cre (24), finding that loss of ESAM+ cDC2s is associated
with reduced resistance to C. rodentium infection but normal
responses to T. gondii and Schistosoma mansoni infection (15,
Significance
High-affinity antibody responses involve selection of B cells in
the germinal center (GC) by cognate interactions with T follicular
helper (TFH) cells, which in turn must first be activated by classical
dendritic cells (cDCs). We observe that Notch2-dependent cDC2s
are required in vivo for induction of TFH cells, GC B cells, and
specific antibody production in response to sheep red blood cell
(SRBC) immunization. Notch2 signaling impacted a broad tran-
scriptional program in cDC2s both at homeostasis and after SRBC
immunization, although we have not identified a target gene
that mediates TFH differentiation. Thus, Notch2 is a transcription
factor that acts in cDCs and is selectively required for support of
the GC reaction.
Author contributions: C.G.B., T.L.M., and K.M.M. designed research; C.G.B., A.T.S., J.T.D.,
S.T.F., V.D., P.B., K.W.O., and D.J.T. performed research; C.G.B., J.T.D., V.D., P.B., D.J.T., and
K.M.M. analyzed data; and C.G.B., T.L.M., and K.M.M. wrote the paper.
Reviewers: J.G.C., University of California, San Francisco; and M.C.N., The Rockefeller
University and Howard Hughes Medical Institute.
The authors declare no conflict of interest.
This open access article is distributed under Creative Commons Attribution-NonCommercial-
NoDerivatives License 4.0 (CC BY-NC-ND).
Data deposition: Gene expression microarray data have been deposited in the Gene
Expression Omnibus (accession no. GSE119242).
1To whom correspondence should be addressed. Email: kmurphy@wustl.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1809925115/-/DCSupplemental.
Published online October 2, 2018.
10726–10731 | PNAS | October 16, 2018 | vol. 115 | no. 42 www.pnas.org/cgi/doi/10.1073/pnas.1809925115
17). cDC2s have been linked to priming CD4+ T cells, but no
studies have directly tested whether Notch2-dependent cDC2
function development of TFH cells. We began by immunizing
mice with SRBCs, which can induce responses by activating
splenic CD4+ cDC2s (33). Wild-type (WT) and CD11c-Cre+
Notch2f/f mice (Notch2Δ11c) were immunized i.p. and analyzed
for TFH cell differentiation and GC B cell formation (Fig. 1). As
a control for specificity, we also tested Batf3−/− mice, which lack
cDC1s (34). WT mice showed robust induction of PD-1+
CXCR5+ TFH cell differentiation after immunization with
SRBCs (Fig. 1 A and B). Batf3−/− mice also supported induction
by SRBCs of TFH cell development, even though they exhibit
higher background before immunization compared with WT
mice. In contrast, Notch2Δ11c mice showed no significant induc-
tion of TFH cells in response to SRBC immunization (Fig. 1 A
and B). Similarly, WT and Batf3−/− mice both showed induction
of GL-7+ Fas+ GC B cells in response to SRBC immunization,
while Notch2Δ11c mice showed no induction (Fig. 1 C and D).
Furthermore, WT mice exhibited high titers of circulating anti-
SRBC IgG1 titers at 17 d after immunization with SRBCs (Fig.
1E). Meanwhile, low anti-SRBC IgG1 titers were detected in
sera in only one of five Notch2Δ11c mice immunized with SRBCs
(Fig. 1E).
As another control, we examined mice with conditional de-
letion of Klf4 in cDCs induced by CD11c-Cre (Klf4Δ11c) (Fig. 1 F
and G). We previously reported that Klf4Δ11c mice show a defect
in protection against S. mansoni owing to decreased TH2 re-
sponses (15). Klf4Δ11c mice were able to produce normal TFH and
GC B cell responses similar to littermate WT control mice in
response to SRBC immunization (Fig. 1 F and G). These find-
ings were confirmed by histological examination of spleen
(Fig. 1H). Both WT and Klf4Δ11c mice generated robust GL7+
GC reactions, but these were not evident in spleen sections of
Notch2Δ11c mice.
We observed similar findings in spleens of WT and Notch2Δ11c
mice immunized with heat-inactivated Listeria monocytogenes
(ΔLM-OVA) (SI Appendix, Fig. S1). WT mice immunized with
ΔLM-OVA generated robust TFH cells and GC B cell reactions.
In contrast, TFH cells and GC B cell reactions were missing in
immunized Notch2Δ11c mice. Similarly, histological analysis of
splenic sections showed robust GL7+ GC responses in WT mice,
but not in Notch2Δ11c mice, immunized with ΔLM-OVA. Small
intestine CD103+CD11b+ cDC2s, like splenic ESAM+ cDC2s,
also require Notch2 signaling for their development (17). Thus,
we examined whether TFH and GC reactions in PPs were im-
pacted by the absence of this subset. However, we found similar
percentages of TFH and GC B cells in PPs fromWT andNotch2
Δ11c
mice at steady state (SI Appendix, Fig. S2). Overall, these findings
indicated a requirement for Notch2-dependent cDC2s in mediating
GC responses in the spleen.
Notch2-Deficient cDC2s Have an Altered Transcriptional Response to
SRBC Immunization. Deletion of Notch2 is known to inhibit the
terminal maturation of splenic DCs (16, 17). However, whether
the DC2s developing in Notch2Δ11c maintain their DC identity
or acquire a macrophage phenotype has been unclear. We
measured intracellular levels of Zbtb46 expression in WT and
Notch2Δ11c DCs, since expression of this transcription factor
distinguishes DCs from macrophages (35, 36), (SI Appendix, Fig.
S3). We found that both DC1s and DC2s from Notch2Δ11c mice
expressed Zbtb46 but not the macrophage surface marker F4/80
(37). Furthermore, the abundance of Zbtb46 was comparable in
WT and Notch2Δ11c cDCs. These results imply that cDC2s in
Notch2Δ11c mice retain their cDC identity.
We previously reported the transcriptional impact of Notch2
signaling during the terminal maturation of cDC2s at steady
state, but not during DC activation (17). To examine the effect of



















































































































Fig. 1. Notch2-dependent DCs are required for
GC reactions after immunization with SRBCs. (A)
Representative flow cytometry analysis of TFH cells
(B220−TCR-β+CD4+CD8-CD44+) from the indicated
mice 8 d after immunization with SRBCs. Shown as
controls are untreated mice. (B) Quantification of the
TFH percentages in the indicated mice from A. (C)
Representative flow cytometry analysis of GC B cells
(B220+CD19+IgD−) in spleens of the same mice as in
A. (D) Quantification of GC B cells in the indicated
mice from C. Each dot represents a biological repli-
cate from three independent experiments. (E) Serum
anti-SRBC IgG1 titers in WT and Notch2 Δ11c mice at
17 d after immunization. Each dot represents a bi-
ological replicate. (F and G) Quantification of TFH and
GC B cells in Klf4Δ11c mice and littermate controls 8
d after immunization with SRBCs. Each dot represents
a biological replicate from two independent experi-
ments. (H) Microscopy of spleens from the indicated
genotypes taken 8 d after immunization with SRBCs.





















splenic cDC2s from untreated WT and Notch2Δ11c mice and
from WT and Notch2Δ11c mice at 24 h after immunization with
SRBCs and carried out global gene expression analysis (Fig. 2).
We identified a fourfold induction of Stat4 in WT cDC2s after
treatment that did not occur in Notch2Δ11c cDC2s (Fig. 2A). At
steady state, Havcr2, which encodes for Tim-3, a marker of T cell
exhaustion (38), was fourfold higher in WT cDC2s compared
with Notch2Δ11c cDC2s (Fig. 2B). In response to SRBC immu-
nization, Notch2-deficient cDC2s, but not WT cDC2s, showed
increased expression of CD14, the coreceptor for LPS, and
Ccl17, a T-cell chemoattractant that acts through CCR4 (Fig.
2C). In addition, we observed an up-regulation of several
members of the SLAM family of surface receptors in Notch2-
deficient cDC2s compared with WT at steady state and on ac-
tivation (Fig. 2D).
Tim-3 Expression by DC2 Requires Notch2 Signaling but Is Dispensable
for GC Reactions. Tim-3 is a marker of differentiated TH1 cells
(39), and Tim-3 binding to galectin-9 promotes peripheral toler-
ance and inhibits TH1 activity (40, 41). Tim-3 is also expressed on
CD8+ tumor-infiltrating lymphocytes (TILs), and Tim-3+PD-1+
TILs fail to proliferate or produce the proinflammatory cytokines
IL-2, TNF, and IFN-γ (42). Combined anti-PD-1 and anti-Tim-3
immunotherapy promotes antitumor responses in mice bearing
solid tumors (42). At steady state, cDC2s express Tim-3, and
combined stimulation in vitro with LPS and galectin-9 induces
TNF-α secretion by WT cDCs, but not Tim-3–deficient DCs (43).
However, the regulation of Tim-3 expression on cDC2s, and
whether it promotes GC reactions, have not been studied.
We first confirmed the reduction in Havcr2 gene expression in
Notch2Δ11c cDC2s at the level of protein expression. We pre-
viously found that loss of Notch2 signaling in cDCs impacted
both splenic cDC subsets, including a reduction in ESAM ex-
pression by both cDC1s and cDC2s (17). Tim-3 expression was
not reduced in Notch2Δ11c cDC1s (Fig. 3A) but was reduced
sixfold in Notch2Δ11c cDC2s compared with WT controls (Fig. 3
A and B). In a murine model of hepatitis C virus, antibody-
mediated blockade of Tim-3 enhanced T cell proliferation and
IFN-γ production induced by HCV antigens (44). To test
whether Tim-3 is required for the formation of GC reactions, we
treated WT B6 mice with a blocking antibody against Tim-3
before SRBC immunization. We confirmed that Tim-3 blockade
on cDC2s was effective by FACS analysis of DCs from mice
treated with anti-Tim-3 or anti-trinitrophenol (clone 2A3) as iso-
type control in untreated controls and in mice immunized with
SRBCs (SI Appendix, Fig. S4A). In mice treated with isotype an-
tibody, we observed high expression of Tim-3 on DC2s irrespective
of SRBC treatment. In contrast, the mean fluorescence intensity
of Tim-3 staining on cDC2s was significantly reduced compared
with that seen in mice treated previously with anti-Tim-3–blocking
antibody (SI Appendix, Fig. S4A), showing that Tim-3 blockade
was achieved. However, mice treated with anti-Tim-3 continued to
support development of TFH cells (Fig. 3 C and D) and GC B cells
(Fig. 3 C and D) in response to SRBCs, similar to isotype-treated
controls. These results suggest that, despite Notch2-dependent
expression by DC2, Tim-3 is not required for TFH or GC reactions.
Notch2-Dependent cDC2s Mediate GC Reactions Independently of
CD25 or STAT4. Differentiation of naïve CD4+ T cells into TFH
cells requires the inhibition of IL-2 signaling (45), which is
promoted by cDC-specific secretion of CD25 (IL-2Rα). We hy-
pothesized that the deficiency in GC reactions in Notch2Δ11c
mice was due to impaired expression of CD25. First, we con-
firmed that cDC2s, but not cDC1s, induce CD25 after immuni-
zation with SRBC (Fig. 4A), as previously reported (29).
However, we found that cDC2 expression of CD25 occurred
independently of Notch2 signaling (Fig. 4A), suggesting the lack
of GC reactions we observed in Notch2Δ11c mice was due to a
distinct mechanism other than IL-2 inhibition.
In our gene expression analysis, we observed Notch2-dependent
induction of STAT4 in cDC2s after SRBC immunization (Fig.
2A). STAT4 expression is reported to increase during DC matu-
ration in vitro (46). In addition, monocyte-derived DCs generated
by culture of peripheral blood monocytes with GM-CSF and IL-4
induce STAT4 after treatment with IFN-γ and LPS (47). How-
ever, the activity of STAT4 in DC function has not been studied
in vivo. To test if STAT4 mediated the requirement for Notch2
signaling in GC reactions, we immunized WT and Stat4−/− mice
with SRBCs and analyzed induction of GC responses (Fig. 4B).
However, we found no difference in the percentages of TFH and
GC B cells between WT and Stat4−/− mice (Fig. 4B). We con-


































































Fig. 2. Expression of Stat4, Tim-3, and SLAM family
of proteins by DC2s is regulated by Notch2 signaling.
Splenic DC2s (B220-CD11c+MHC-II+CD172a+) were
sorted from WT and Notch2Δ11c mice at 24 h after
immunization with SRBCs or untreated controls and
analyzed for gene expression by microarray. (A and
B) Heatmap of expression of the top 10 probe sets
down-regulated in Notch2Δ11c DC2s compared with
WT after SRBC immunization (A) or at steady state
(B). (C) Heatmap of expression of the top-10 tran-
scripts up-regulated in Notch2Δ11c DC2s compared
with WT DC2s after immunization with SRBCs. (D)
Heatmap of SLAM family protein expression. Each
column represents a biological replicate from two
independent experiments.
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spleen using histological analysis of GL7+ GC B cells in splenic
sections (Fig. 4C). Again, WT and Stat4−/− mice showed similar
levels of GC formation in response to SRBC immunization.
Notch2 Signaling Represses Antigen Presentation Efficiency of cDC2s.
Antigen presentation by cDCs is necessary to prime CD4+ T cells
against soluble antigens in vivo (48). Previous work has shown
that cDCs are necessary and sufficient to initiate TFH responses
(26, 49). Antigen targeting to each cDC subset revealed that
cDC2s are more efficient than cDC1 at presenting antigens on
MHC-II molecules (6) and in promoting TFH differentiation
(31). To test whether Notch2Δ11c cDC2s have a defect in priming
CD4+ T cells, we examined their efficiency in presenting soluble
antigens to OT-II cells. To do so, we cocultured sorted cDC2s
from WT or Notch2Δ11c mice and CFSE-labeled OT-II T cells in
the presence of varying concentrations of soluble OVA protein.
We observed a 30-fold increase in the efficiency of antigen
presentation by Notch2-deficient cDC2s compared with WT
DC2s (Fig. 5A). We also tested whether Notch2 signaling re-
pressed antigen presentation efficiency by measuring the en-
dogenous ESAM+ or ESAM− populations of cDC2s that are
present in WT mice, since we previously determined that the
ESAM+ cDC2 subset represents the Notch2-dependent pop-
ulation in vivo (17). Therefore, we tested priming of OT-II
T cells by endogenous ESAM+ or ESAM− cDC2s (Fig. 5B).
Notably, we found that the ESAM− cDC2 population was able to
activate OT-II T cells at a significantly lower concentration of
soluble OVA than the ESAM+ cDC2 population. Furthermore,
the efficiency of ESAM− cDC2s was similar to the efficiency
of Notch2Δ11c cDC2s, both of which were more efficient than
ESAM+ cDC2s (Fig. 5B).
The SLAM family of receptors, which includes CD84 and
Ly108, engage in high-affinity homotypic interactions (50). Sig-
naling by these receptors is mediated by the SLAM-associated
protein (SAP), encoded by Sh2d1a, which binds to the intracel-
lular tail of SLAM receptors via an SH2 domain. T cells lacking
SAP are unable to form stable interactions with their cognate B
cell and Sh2d1a−/−mice lack T-dependent antibody responses due
to deficient help from SAP-deficient T cells to B cells (51, 52).
SAP-deficient OT-II cells cannot differentiate into TFH cells and
are unable to localize to the GC reaction (49). We found in-
creased expression of several SLAM receptors by Notch2-deficient
cDC2s (Fig. 2D). We wondered whether the increased efficiency
in antigen presentation by Notch2-deficient cDC2s to OT-II cells
(Fig. 5 A and B) was a result of increased SLAM expression and
stabilization of DC:T interactions. Therefore, we examined the
antigen presentation efficiency of sorted ESAM+ and ESAM−
cDC2s from spleens of WT and Sh2d1a−/− mice. We found that
both WT and SAP-deficient ESAM− cDC2s induced OT-II pro-
liferation with similar efficiency, and in both cases, there were
significantly more efficient that their ESAM+ DC2 counterparts
(Fig. 5C). Thus, while Notch2-deficient DC2s are more efficient at
priming CD4+ T cells to soluble antigens, this activity was in-
dependent of SLAM signaling.
Discussion
We previously reported a requirement for Notch2-dependent
cDC2s in innate defense against C. rodentium mediated by IL-
23 (17). A role for Notch2-dependent cDC2s in regulating
adaptive immunity was implied by a twofold reduction in TH17
cells in intestinal lamina propria in Notch2Δ11c mice at steady
state (16). However, Notch2-dependent cDC2s are not required
for TH17 responses to Streptococcus pyogenes (53), to segmented
filamentous bacteria (SFB) (54), TH2 responses against S.
mansoni (15), or development of peripheral Treg cells (55). This
study identifies a role Notch2-dependent DC2s in mediating TFH
differentiation and splenic GC responses to certain modes of
immunization.
TFH differentiation occurs rapidly after immunization (56).
TFH cells are distinguished by expression of CXCR5 and down-
regulation of CD25 (57). T cell priming by DCs proceeds
through three phases, beginning with short T:DC interactions,
followed by long-term T:DC conjugates that induce cytokine
production and T cell proliferation, and finally a return to short-
term contact and T cell migration (58). The long-term T:DC
interactions leading up to the third stage are required for TFH
differentiation (59). In some settings, DCs are sufficient for TFH
differentiation. With high antigen concentrations, B cells appear
dispensable for TFH differentiation, and persistent antigen pre-
sentation by DCs appears to be sufficient to induce full TFH
maturation (26, 49). Higher antigen levels and longer dwelling


















































































































Fig. 3. Tim-3 expression on DC2s requires Notch2 signaling but is dispens-
able for GC reactions after immunization with SRBC. (A) Flow cytometry
analysis of Tim-3 surface expression on DC1s (CD24+CD172a−) and DC2s
(CD24−CD172a+) from WT or CD11c-Cre+ Notch2f/f (Notch2Δ11c) splenocytes.
(B) Quantification of the percentage of Tim-3–expressing DCs from A. Each
dot represents a biological replicate from five independent experiments.
(C–F) WT mice treated with anti-Tim-3–blocking antibody (clone RMT3-23)
or isotype IgG as a control were immunized with SRBCs and analyzed for GC
reactions after 8 d. (C) Representative flow cytometry analysis of TFH differ-
entiation (B220−TCR-β+CD4+CD8−CD44+). (D) Quantification of TFH percent-
ages in spleens of the indicated mice treated as in E. (E) Flow cytometry
analysis of GC B cells (B220+CD19+IgD−) in spleens of mice treated as in E. (F)
Quantification of splenic GC B cells in mice treated as in E. Each dot represents
a biological replicate.





















perhaps suggesting that stronger TCR signaling favors TH1 over
TFH differentiation.
Notch2 signaling during cDC2 development appears to de-
crease the efficiency of antigen presentation, an effect evident in
direct comparisons between endogenous ESAM+ and ESAM−
cDC2 populations in the spleen. Splenic ESAM+ cDC2s are
Notch2-dependent and develop through encounters with Delta-
like 1 (61). Conceivably, the greater efficiency of antigen pre-
sentation by Notch2-deficient DC2s provides stronger TCR sig-
naling, which might not be favorable to TFH differentiation. Loss
of Notch2 on cDC2s increased the expression of multiple SLAM
proteins, which stabilize B/T conjugates that promote TFH mat-
uration in GCs (49). However, the increased OT-II proliferation
induced by Notch2Δ11c DC2s was not dependent on SAP, the
SLAM signaling mediator (51, 52), suggesting that changes in
other molecules may be involved.
We previously reported an approximate twofold reduction in
the total number of cDC2s in spleens from Notch2Δ11c mice
compared with littermate controls (17). Conceivably, this reduc-
tion in cDC2s alone might be the cause of impaired GC reactions
in response to SRBCs. However, WT and Notch2-deficient cDC2s
showed qualitative changes in gene expression. Notch2 signaling
has a pleiotropic impact in the development and function of
cDC2s, which might contribute to the absence of GC reactions
reported here. We previously reported that at steady state,
Notch2-deficient cDC2s are reduced threefold in splenic and gut
tissues, and in a competitive setting, these cDC2s are outcompeted
by their WT counterparts (17). However, we also find that after
activation with SRBCs, more than 2,000 genes are differentially
expressed between WT and Notch2Δ11c cDC2s. While we have
ruled out the involvement of some Notch2 targets, like STAT4
and Tim-3, in the induction of GC reactions in response to
SRBCs, other pathways regulating cDC2 activation of TFH and
GC B cells may be dependent on Notch2 activity. For example,
GC reactions require the correct localization of DCs, B cells, and
CD4+ T cells. The G protein-coupled receptor Ebi2 (GPR183) is
involved in colocalization of activated cDC2s, T cells, and B cells
at the follicle–T zone interface in the spleen (62–64). Correct
positioning of cDC2s supports the induction of TFH and GC re-
actions (65). cDC2 localization within the MZ bridging channels
also requires Notch2 signaling (17). While Notch2-deficient cDC2s
can prime CD4+ T cells in vitro, the lack of ESAM+ cDC2s lo-
cated in the bridging channel may impair TFH differentiation from
lack of proximity to the B cell follicle in vivo. Further work is
needed to determine the involvement of Notch2 signaling in DC
localization and its role in TFH development.
Materials and Methods
Mice. The followingmicewere acquired from Jackson Laboratories: CD11c-Cre
[B6.Cg-Tg(Itgax-cre)1–1Reiz/J], Notch2f/f (B6.129S-Notch2tm3Grid/J), CD45.1+ B6.
SJL (B6.SJL-PtprcaPepcb/BoyJ), Stat4−/− (C57BL/6J-Stat4em3Adiuj/J), and Sh2d1a−/−
(B6.129S6-Sh2d1atm1Pls/J). Notch2f/f mice were crossed to CD11c-Cre mice to
generate Notch2Δ11cmice. The generation of Zbtb46gfp/gfp and Batf3−/−mice has
been described previously (34, 36). Klf4f/f mice were obtained from the Mutant
Mouse Resource and Research Center (MMRRC; line 29877) and crossed to CD11c-
Cre mice to generate Klf4Δ11c mice. All mice were maintained on the C57BL/6
background in a specific pathogen-free animal facility following institutional
guidelines and with protocols approved by the Animal Studies Committee at
Washington University in St. Louis. Experiments were performed with mice age
8–12 wk using sex-matched littermates.
Antibodies and Flow Cytometry. Cells were kept at 4 °C while being stained in
PBS with 0.5% BSA and 2 mM EDTA in the presence of CD16/32 Fc block (BD;
clone 2.4G2). For intracellular flow cytometry, cells were stained for surface
markers, permeabilized, and fixed with the transcription buffer set (BD)
following the manufacturer’s instructions. Cells were then stained for in-
tracellular Zbtb46 expression at 4 °C on ice. Cells were analyzed on a FACS


















































































WT Stat4–/–C Fig. 4. Notch2-dependent DCs do not require CD25or Stat4 to induce GC reactions. (A). Representative
flow cytometry analysis of CD25 expression on
splenic cDCs from WT or Notch2Δ11c mice at 24 h
after immunization with SRBCs. Shown are two-color
histograms for CD25 expression on DCs from un-
treated mice as controls. (B) WT and Stat4−/− mice
were immunized with SRBCs and analyzed for GC
reactions after 8 d. Quantification of TFH and GC B
cells. Each dot represents a biological replicate from
three independent experiments; unimmunized mice
are shown as controls. (C) Microscopy of splenic GC
reactions in WT and Stat4−/− mice immunized with














































Fig. 5. Notch2 signaling programs DC2 for reduced priming efficiency in-
dependent of SLAM signaling. (A) Soluble antigen presentation assay of WT
and Notch2Δ11c sorted DC2s. Shown is the mean percentage of CFSE dilution
in OT-II cells at 3 d after coculture. (B) Splenic ESAM+ and ESAM− DC2s from
WTmice were cocultured with OT-II CD4 T cells as in A. The mean percentage
CFSE dilution in OT-II cells after 3 d of culture is shown. n = 6 biological
replicates for ESAM+ and ESAM− WT DC2s; n = 2 for Notch2Δ11c DC2s. (C)
Splenic ESAM+ and ESAM− DC2s from WT and Sh2d1a−/− mice were cocul-
tured with OT-II T cells as in A.
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analyzed with FlowJo software (Tree Star). Antibodies and other staining
materials are described in SI Appendix, Materials and Methods.
Statistical Analysis. In the figures, error bars indicate the SEM. Statistical
analyses were performed using two-way ANOVA with Sidak’s multiple-
comparison test. All statistical analyses were performed using Prism (GraphPad
Software).
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